The Decoder
OpenAI acquires Orchestra Bio to build AI agents that speed up drug development

OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind.
Read at The Decoder ↗Related
ValleyOpenAI acquires Orchestra Bio to bring AI agents into drug development SiliconANGLE

EuropeDaytona hits $1B valuation with $60M Series B for AI agent cloud Tech.eu

AsiaAutonomous delivery vehicle maker Neolix raises nearly $400 million in Series E funding TechNode

VoicesNew paper: Emerging trends in AI agent evaluation AI Snake Oil

AsiaHunar Raises ₹40 Cr To Scale Agentic AI For Frontline Hiring Inc42
